pISSN 1226-6051
eISSN 2508-786X
eISSN 2508-786X
Topics in Korean Clinical Practice Guideline for Stoke (KCPGS) explaining antithrombotic therapy
1. Primary prevention of stroke |
1.2. Well-documented and modifiable risk factors |
1.2.4. Atrial fibrillation (2012) |
1.4. Aspirin for primary stroke prevention (2011) |
2. Acute stroke management |
2.3. Acute treatment |
2.3.2. Prevention and management of medical complication |
2.3.2.1. Deep vein thrombosis prophylaxis (2009) |
2.3.3. Thrombolysis |
2.3.3.1. Intravenous thrombolysis (2012) |
2.3.3.2. Endovascular recanalization therapy in acute ischemic stroke (2016) |
2.3.4. Antiplatelet agents (2009 ➔ 2022) |
2.3.5. Anticoagulants (2009 ➔ 2022) |
3. Secondary prevention of stroke |
3.2. Antithrombotic therapy for noncardioembolic stroke or transient ischemic attack |
3.2.1. Antiplatelet therapy |
3.2.1.1. Aspirin (2010) |
3.2.1.2. Thienopyridine (2010) |
3.2.1.3. Other antiplatelet agents: triflusal, dipyridamole, cilostazol (2012) |
3.2.1.4. Antiplatelet combination therapy (2009) |
3.2.2. Anticoagulants (2009) |
3.2.3. Specific consideration of antiplatelet agents (2009) |
3.2.3.1. Ischemic stroke while taking antiplatelet agent |
3.2.3.2. Ischemic stroke mixed with hemorrhage |
3.3. Antithrombotic therapy of cardioembolic stroke or transient ischemic attack |
3.3.1. Anticoagulants (2009) |
3.3.2. Antiplatelet therapy or combination therapy (2009) |
3.3.3. Specific conditions |
3.3.3.1. Atrial fibrillation (2014) |
3.3.3.2. Congestive heart failure (2009) |
3.3.3.3. Acute myocardial infarction (2009) |
3.3.3.4. Valvular heart disease (2009) |
3.4. Surgical or interventional treatment of large artery steno-occlusive disease |
3.4.1. Extracranial carotid artery stenosis (2011) |
3.5. Management of other specific conditions (2009) |
3.5.2. Secondary prevention in ischemic stroke mixed with hemorrhage |
3.5.3. Arterial dissection |
3.5.4. Patent foramen ovale and atrial septal aneurysm |
3.5.5. Antiphospholipid antibody syndrome |
3.5.6. Venous infarction |
KCPGS, Korean Clinical Practice Guideline for Stroke
Latest revision years are in parenthesis